Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

PIRS

Pieris Pharmaceuticals (PIRS)

Pieris Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:PIRS
DateTimeSourceHeadlineSymbolCompany
17/12/202411:44Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:PIRSPieris Pharmaceuticals Inc
17/12/202411:44Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:PIRSPieris Pharmaceuticals Inc
17/12/202411:43Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:PIRSPieris Pharmaceuticals Inc
17/12/202411:43Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:PIRSPieris Pharmaceuticals Inc
17/12/202411:42Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:PIRSPieris Pharmaceuticals Inc
17/12/202408:18Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PIRSPieris Pharmaceuticals Inc
13/12/202408:15Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:PIRSPieris Pharmaceuticals Inc
13/12/202408:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PIRSPieris Pharmaceuticals Inc
07/12/202406:21Edgar (US Regulatory)Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:PIRSPieris Pharmaceuticals Inc
04/12/202400:30Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:PIRSPieris Pharmaceuticals Inc
04/12/202400:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PIRSPieris Pharmaceuticals Inc
19/11/202408:16Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:PIRSPieris Pharmaceuticals Inc
15/11/202401:07Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:PIRSPieris Pharmaceuticals Inc
14/11/202408:02Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PIRSPieris Pharmaceuticals Inc
12/11/202416:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:PIRSPieris Pharmaceuticals Inc
08/11/202401:01Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:PIRSPieris Pharmaceuticals Inc
08/11/202400:30GlobeNewswire Inc.Palvella Therapeutics Announces First Patient Dosed in SELVA Phase 3 Clinical Trial of QTORINâ„¢ 3.9% Rapamycin Anhydrous Gel (QTORINâ„¢ rapamycin) for the Treatment of Microcystic Lymphatic MalformationsNASDAQ:PIRSPieris Pharmaceuticals Inc
07/11/202409:01Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:PIRSPieris Pharmaceuticals Inc
07/11/202409:00Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:PIRSPieris Pharmaceuticals Inc
17/10/202423:00Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:PIRSPieris Pharmaceuticals Inc
17/10/202422:30GlobeNewswire Inc.Palvella Therapeutics Appoints Matthew E. Korenberg as Chief Financial OfficerNASDAQ:PIRSPieris Pharmaceuticals Inc
15/10/202423:00Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:PIRSPieris Pharmaceuticals Inc
03/10/202422:00Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:PIRSPieris Pharmaceuticals Inc
03/10/202422:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PIRSPieris Pharmaceuticals Inc
15/08/202406:01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PIRSPieris Pharmaceuticals Inc
13/08/202408:48Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PIRSPieris Pharmaceuticals Inc
09/08/202406:17Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:PIRSPieris Pharmaceuticals Inc
09/08/202406:17Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PIRSPieris Pharmaceuticals Inc
08/08/202404:16Edgar (US Regulatory)Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:PIRSPieris Pharmaceuticals Inc
01/08/202422:00Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:PIRSPieris Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:PIRS